 ADC Therapeutics SA NYSE:ADCT Q1 2022 Earnings Conference Call May 9, 2022 8:30 AM ET Company Participants Amanda Hamilton - Investor Relations Manager Chris Martin - Former Chief Executive Officer Jennifer Herron - Chief Commercial Officer Joe Camardo - Chief Medical Officer Jenn Creel - Chief Financial Officer Ameet Mallik - Chief Executive Officer Conference Call Participants Kelly Shi - Jefferies Operator Welcome to the ADC Therapeutics First Quarter 2022 Financial Results Conference Call. My name is Mitchell and I will be your operator for todays call. 